doi: 10.3389/fphar.2014.00151 Received 27 May 2014 Accepted 10 June 2014 Published 01 July 2014 Volume 5 - 2014 Edited by Alfonso Pompella, Universit di Pisa, Italy Reviewed by Richard Eugene Frye, Childrens Hospital Boston/Harvard Univerity, USA
Sucic, M
Well also cover when it may become available in the UK, possible side effects, and how it compares with treatments like Mounjaro injections, Wegovy injections and the Wegovy pill
Individual variation is significant, likely depending on baseline GLP-1 receptor density, drinking patterns, genetic factors, and dose
Invigors model is mostly prescription and check-ins, and research shows combining behavioral programs with GLP-1 treatments leads to significantly better long-term results